NICE recommends Kymriah® for routine NHS use, offering immense benefits for those with resistant B-...
We explore CAR T-cell therapy challenges, regulatory approvals, market growth, pricing models, and a...
Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.
Δ